Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?

Groeneveldt, C; van den Ende, J; van Montfoort, N

Groeneveldt, C (通讯作者),Leiden Univ, Oncode Inst, Dept Med Oncol, Med Ctr, NL-2333 ZA Leiden, Netherlands.

CYTOKINE & GROWTH FACTOR REVIEWS, 2023; 70 (): 1

Abstract

Oncolytic viruses (OVs) represent a highly promising treatment strategy for a wide range of cancers, by medi-ating both the direct killing of tumor ce......

Full Text Link